Methylation of the TWIST1 Promoter, TWIST1 mRNA Levels, and Immunohistochemical Expression of TWIST1 in Breast Cancer

TWIST1, an antiapoptotic and prometastatic transcription factor, is overexpressed in many epithelial cancers including breast. Only little is known regarding the regulation of TWIST1 in these cancers. Recently, an increase in the TWIST1 promoter methylation has been shown in breast cancers. To correlate the percentage of TWIST1 promoter methylation to the protein levels, we analyzed simultaneously the methylation status as well as the mRNA and the percentage of cells expressing TWIST1 in normal breast tissue and 76 invasive breast cancers. We found that TWIST1 promoter methylation is significantly more prevalent in malignant compared with healthy breast tissue. Furthermore, the percentage of cells expressing TWIST1 was greater in breast malignancy compared with matched healthy tissue from the same patients. There was no correlation, however, between TWIST1 promoter methylation and TWIST1 protein or RNA expression. This indicates that although TWIST1 CpG methylation is useful as a biomarker in breast cancer diagnosis, there is no direct correlation with TWIST1 expression. (Cancer Epidemiol Biomarkers Prev 2008;17(12):3325–30)

[1]  M. Fackler,et al.  Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  D. Coppola,et al.  Twist Is Transcriptionally Induced by Activation of STAT3 and Mediates STAT3 Oncogenic Function* , 2008, Journal of Biological Chemistry.

[3]  R. Plasterk,et al.  The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2α , 2008, Oncogene.

[4]  Kou-Juey Wu,et al.  Direct regulation of TWIST by HIF-1α promotes metastasis , 2008, Nature Cell Biology.

[5]  H. Grönberg,et al.  Women with Saethre‐Chotzen syndrome are at increased risk of breast cancer , 2007, Genes, chromosomes & cancer.

[6]  Héctor Peinado,et al.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.

[7]  Wenlin Huang,et al.  The clinical significance of twist expression in nasopharyngeal carcinoma. , 2006, Cancer letters.

[8]  Sheung Tat Fan,et al.  Twist Overexpression Correlates with Hepatocellular Carcinoma Metastasis through Induction of Epithelial-Mesenchymal Transition , 2006, Clinical Cancer Research.

[9]  Zhe Zhang,et al.  Quantitative Multiplex Methylation-Specific PCR Analysis Doubles Detection of Tumor Cells in Breast Ductal Fluid , 2006, Clinical Cancer Research.

[10]  S. Kyo,et al.  High Twist expression is involved in infiltrative endometrial cancer and affects patient survival. , 2006, Human pathology.

[11]  C. Glackin,et al.  N-cadherin gene expression in prostate carcinoma is modulated by integrin-dependent nuclear translocation of Twist1. , 2006, Cancer research.

[12]  P. V. van Diest,et al.  Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer. , 2005, Cancer research.

[13]  Gary L Rosner,et al.  Tumour vasculature: On the verge of collapse , 2005, Nature Reviews Cancer.

[14]  Xiaomeng Zhang,et al.  Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. , 2005, Cancer research.

[15]  G. Watkins,et al.  Expression of the Transcription Factors Snail, Slug, and Twist and Their Clinical Significance in Human Breast Cancer , 2005, Annals of Surgical Oncology.

[16]  O. Watanabe,et al.  Expression of twist and wnt in human breast cancer. , 2004, Anticancer research.

[17]  J. Herman,et al.  Hypermethylation in Histologically Distinct Classes of Breast Cancer , 2004, Clinical Cancer Research.

[18]  Pedram Argani,et al.  Quantitative Multiplex Methylation-Specific PCR Assay for the Detection of Promoter Hypermethylation in Multiple Genes in Breast Cancer , 2004, Cancer Research.

[19]  J. Herman,et al.  Promoter Hypermethylation of Resected Bronchial Margins , 2004, Clinical Cancer Research.

[20]  S. Ramaswamy,et al.  Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.

[21]  G. Parmigiani,et al.  Estrogen Receptor/Progesterone Receptor-Negative Breast Cancers of Young African-American Women Have a Higher Frequency of Methylation of Multiple Genes than Those of Caucasian Women1 , 2004, Clinical Cancer Research.

[22]  M. Justice,et al.  A twist code determines the onset of osteoblast differentiation. , 2004, Developmental cell.

[23]  M. Fackler,et al.  DNA methylation of RASSF1A, HIN‐1, RAR‐β, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma , 2003, International journal of cancer.

[24]  Martin Widschwendter,et al.  DNA methylation and breast carcinogenesis , 2002, Oncogene.

[25]  J. Thiery.  Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[26]  P. V. van Diest.  No consent should be needed for using leftover body material for scientific purposes. For. , 2002, BMJ.

[27]  A. Wilkie,et al.  Genetics of craniofacial development and malformation , 2001, Nature Reviews Genetics.

[28]  Christopher B Umbricht,et al.  Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR , 2001, The Lancet.

[29]  J. Herman,et al.  DNA hypermethylation in tumorigenesis: epigenetics joins genetics. , 2000, Trends in genetics : TIG.

[30]  C. Glackin,et al.  TWIST, a basic helix‐loop‐helix transcription factor, can regulate the human osteogenic lineage , 1999, Journal of cellular biochemistry.

[31]  L. Kedes,et al.  Twist is a potential oncogene that inhibits apoptosis. , 1999, Genes & development.

[32]  J. Peterse,et al.  Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project. , 1992, Human pathology.